Funding from the following sources is gratefully acknowledged: Canadian Institutes of Health Research (CIHR),
Canada Research Chair and Canada Foundation for
Innovation programs, the Davey Endowment and the
Abraham and Freda Berger Memorial Fund.
► Anti-Parkinson Drugs
► Antipsychotic Drugs
► Attention Deficit Hyperactivity Disorder
► Bipolar Disorder
► Monoamine Oxidase Inhibitors
Baker GB, Bornstein RA, Yeragani VK (1993) Trace amines and tourette's syndrome. Neurochem Res 18:951-956
Berry MD (2007) The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev Recent Clin Trials 2:3-19
Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966-8971
Was this article helpful?